Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer Research|August 17, 2005
A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastomaBikul Das, Herman Yeger, Rika Tsuchida, et al.
BMC Cancer|February 26, 2017
Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastomaReza Bayat Mokhtari, Narges Baluch, Micky Ka Hon Tsui, et al.
Cancers|July 2, 2021
3D Multicellular Stem-Like Human Breast Tumor Spheroids Enhance Tumorigenicity of Orthotopic Xenografts in Athymic Nude Rat ModelReza Bayat Mokhtari, Bessi Qorri, Manpreet Sambi, et al.
British Journal of Haematology|April 19, 2012
A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potentialChung-Gi Lee, Bikul Das, Tara L Lin, et al.
BMC Cancer|September 1, 2019
Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphaneReza Bayat Mokhtari, Narges Baluch, Evgeniya Morgatskaya, et al.
Frontiers in Immunology|February 18, 2025
Hypoxia-driven mobilization of altruistic cancer stem cells in platinum-treated head and neck cancerLekhika Pathak, Bidisha Pal, Joyeeta Talukdar, et al.
Msystems|August 8, 2019
The Oral Mouse Microbiome Promotes Tumorigenesis in Oral Squamous Cell CarcinomaPhilip Stashenko, Susan Yost, Yoonhee Choi, et al.
Cancers|July 24, 2021
The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance ImmunotherapyReza Bayat Mokhtari, Manpreet Sambi, Bessi Qorri, et al.
Frontiers in Immunology|October 17, 2022
Targeting hypoxia-induced tumor stemness by activating pathogen-induced stem cell niche defenseSeema Bhuyan, Bidisha Pal, Lekhika Pathak, et al.
Oncotarget|July 28, 2021
Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosisReza Bayat Mokhtari, Bessi Qorri, Narges Baluch, et al.
Pageof 4